Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2
Clin Cancer Res
.
2019 Feb 15;25(4):1434.
doi: 10.1158/1078-0432.CCR-18-4267.
Authors
Ariella B Hanker
,
Joan T Garrett
,
Mónica Valeria Estrada
,
Preston D Moore
,
Paula González Ericsson
,
James P Koch
,
Emma Langley
,
Sharat Singh
,
Phillip S Kim
,
Garrett M Frampton
,
Eric Sanford
,
Philip Owens
,
Jennifer Becker
,
M Reid Groseclose
,
Stephen Castellino
,
Heikki Joensuu
,
Jens Huober
,
Jan C Brase
,
Samira Majjaj
,
Sylvain Brohée
,
David Venet
,
David Brown
,
José Baselga
,
Martine Piccart
,
Christos Sotiriou
,
Carlos L Arteaga
PMID:
30770493
DOI:
10.1158/1078-0432.CCR-18-4267
No abstract available
Publication types
Published Erratum